arrow_back Trending Legislation
Share share

Increased Transparency in Drug Pricing and Hospital Rules for 340B Program.

This act aims to increase transparency in the 340B drug discount program, which helps hospitals purchase medications at lower costs. It introduces new rules on which hospitals can participate and how they must report their drug expenditures and revenues. This should help citizens better understand how drug discounts work and whether hospitals pass savings on to patients.
Key points
A 2-year pause on new hospital registrations in the 340B program to establish clear participation rules.
Hospitals will need to disclose how much they earn from discounted drugs and how much they spend on charity care.
Introduction of special codes on drug claims to track which drugs were purchased with 340B discounts.
Greater oversight on which medical facilities (e.g., clinics) can benefit from discounts as part of a hospital.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Drug Pricing Transparency and Accountability Act
Print number: HR 5463
Sponsor: Rep. Rosendale Sr., Matthew M. [R-MT-At Large]
Process start date: 2021-09-30